Multiple roles of short-chain fatty acids in Alzheimer disease

Nutrition. 2022 Jan:93:111499. doi: 10.1016/j.nut.2021.111499. Epub 2021 Sep 23.

Abstract

Alzheimer disease (AD) is the most common form of neurodegenerative disease in older adults and has a complicated etiology. Recently, the roles of short-chain fatty acids (SCFAs), the main metabolites generated by fermentation of dietary fiber by gut microbiota, in the pathogenesis of AD have attracted considerable interest. This study analyzed the multiple roles of SCFAs in AD pathogenesis from five aspects, including: 1) epigenetic regulation; 2) modulation of neuroinflammation; 3) maintenance of the blood-brain barrier (BBB); 4) regulation of brain metabolism; and 5) interference in amyloid protein formation. According to the currently available evidence, SCFAs, particularly butyrate, cause important biological effects that interfere with the development of AD. However, the effect of other SCFAs, such as propionate, on AD might be either beneficial or harmful to different pathways, indicating that the role of SCFAs in the pathogenesis of AD is rather complicated and warrants further investigations.

Keywords: Alzheimer disease; Gut microbiota; Pathogenesis; Short-chain fatty acids.

Publication types

  • Review

MeSH terms

  • Aged
  • Alzheimer Disease*
  • Epigenesis, Genetic
  • Fatty Acids, Volatile
  • Humans
  • Neurodegenerative Diseases*
  • Neuroinflammatory Diseases

Substances

  • Fatty Acids, Volatile